April 2 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PROVIDES UPDATE ON PHASE 2 HUMAN TESTING OF IFENPRODIL FOR COVID-19
* ALGERNON PHARMACEUTICALS - PLANNED PHYSICIAN INITIATED PHASE 2 STUDY OF NP-120 FOR COVID-19 INFECTED PATIENTS IN SOUTH KOREA HAS BEEN FINALIZED